Real-world study of advanced breast cancer treatments withdrawn before starting
NCT ID NCT07076680
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This was an observational study designed to collect medical data from people with HR+/HER2- advanced breast cancer during routine care. The goal was to track treatment effectiveness and side effects in real-world settings. However, the study was withdrawn before enrolling any participants, so no data was collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER, METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- PET scan could reveal which breast cancer patients will respond to targeted therapy
- New study aims to catch lymphedema early in breast cancer patients
- Real-world data may reveal true effectiveness of leading breast cancer therapy
- Mapping the hidden toll: how breast cancer brain metastases affect daily life
- New drug combo shows promise for Hard-to-Treat breast cancer